MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies
- PMID: 20177980
- DOI: 10.1007/s11547-010-0531-2
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies
Abstract
Purpose: The continuous discovery of new subtypes of neuromuscular disorders demands more accurate imaging analyses. We set out to establish the specific patterns of muscular involution using magnetic resonance imaging (MRI).
Materials and methods: A systematic clinical evaluation based on the Medical Research Council scale and MRI was completed in ten patients with calpainopathy [limb-girdle muscular dystrophy (LGMD)-2A], 16 with dysferlinopathy (LGMD-2B), ten with hyaline body myopathy (HBM), six with myotonic dystrophy (MD) types 1 and 5 with MD type 2. Severity of fibroadipose degeneration was specifically staged using T1-weighted sequences. Turbo inversion recovery magnitude (TIRM) sequences were used to assess oedema-like changes.
Results: T1 scans showed recurrent patterns of fibroadipose replacement, whereas TIRM images revealed differences in oedema-like changes between the various diseases. In LGMD, the posterior compartments are more vulnerable to degeneration. In HBM, fatty muscle degeneration and oedema are allocated to muscles of the posterior compartments of the leg. In MD, fatty muscle degeneration and oedematous changes are allocated to muscles of the anterior thigh and posterior lower leg.
Conclusions: Imaging examination suggests a characteristic pattern of muscle involvement. MRI represents an important diagnostic technique useful in differential diagnosis, thanks to the distinctive patterns observed in the distribution of muscular changes between the different muscular diseases.
Similar articles
-
Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy.Chin Med J (Engl). 2018 Jun 20;131(12):1472-1479. doi: 10.4103/0366-6999.233957. Chin Med J (Engl). 2018. PMID: 29893365 Free PMC article.
-
The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.Acta Neuropathol Commun. 2022 Feb 8;10(1):17. doi: 10.1186/s40478-022-01320-z. Acta Neuropathol Commun. 2022. PMID: 35135626 Free PMC article.
-
Clinical and magnetic resonance imaging features of 'diamond on quadriceps' sign in dysferlinopathy.Neurol India. 2009 Mar-Apr;57(2):172-5. doi: 10.4103/0028-3886.51287. Neurol India. 2009. PMID: 19439848
-
Myopathies with finger flexor weakness: Not only inclusion-body myositis.Muscle Nerve. 2020 Oct;62(4):445-454. doi: 10.1002/mus.26914. Epub 2020 Jun 1. Muscle Nerve. 2020. PMID: 32478919 Review.
-
Limb-Girdle Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.2000 Jun 8 [updated 2012 Aug 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2000 Jun 8 [updated 2012 Aug 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301582 Free Books & Documents. Review.
Cited by
-
Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.J Neurol. 2013 May;260(5):1245-57. doi: 10.1007/s00415-012-6779-9. Epub 2012 Dec 23. J Neurol. 2013. PMID: 23263591
-
Muscle MRI in muscular dystrophies.Acta Myol. 2015 Dec;34(2-3):95-108. Acta Myol. 2015. PMID: 27199536 Free PMC article.
-
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials.Eur J Neurol. 2022 Mar;29(3):843-854. doi: 10.1111/ene.15174. Epub 2021 Dec 6. Eur J Neurol. 2022. PMID: 34753219 Free PMC article.
-
Imaging alterations in skeletal muscle channelopathies: a study in 15 patients.Acta Myol. 2015 Dec;34(2-3):109-15. Acta Myol. 2015. PMID: 27199537 Free PMC article.
-
Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up.J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S355-61. doi: 10.1007/s10545-010-9186-3. Epub 2010 Sep 4. J Inherit Metab Dis. 2010. PMID: 20821051
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical